Litcius/Paper detail

Drug retention rates of biological agents in adult onset Still's disease

Corrado Campochiaro, Nicola Farina, Alessandro Tomelleri, Giacomo De Luca, Elena Baldissera, Giulio Cavalli, Lorenzo Dagna

2020Seminars in Arthritis and Rheumatism19 citationsDOI

Topics & Concepts

MedicineDiscontinuationAnakinraTocilizumabInternal medicineConcomitantCohortHazard ratioAdult-onset Still's diseaseRetrospective cohort studyTNF inhibitorEtanerceptRheumatoid arthritisDiseaseConfidence intervalAutoimmune and Inflammatory Disorders ResearchOtitis Media and Relapsing PolychondritisKawasaki Disease and Coronary Complications
Drug retention rates of biological agents in adult onset Still's disease | Litcius